We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Xceleron and Servier Sign Agreement to Accelerate Drug Development

News   Dec 07, 2005

 
Xceleron and Servier Sign Agreement to Accelerate Drug Development
 
 
 

RELATED ARTICLES

Harmful Bacteria Combated by Breast Milk Compound

News

Researchers have identified a compound in human breast milk that fights infections by harmful bacteria while allowing beneficial bacteria to thrive. Future research will determine if the compound could be a beneficial additive to cow’s milk and infant formula.

READ MORE

How Many "Chemical Nasties" Are in Your Take Away?

News

A home-cooked meal has many benefits, including healthier ingredients and fewer processed foods. But there’s another reason to avoid eating out all the time. Preparing meals at home can reduce your exposure to harmful PFAS chemicals that are commonly found in take-out and fast food packaging.

READ MORE

A Way To Extend Survival Rates for Heart Failure?

News

For the first time in preclinical studies, researchers have shown that Aliskiren, a drug that inhibits the enzyme that regulates blood pressure, can delay progression of congestive heart failure and extend survival rates.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE